HUP0300244A2 - Kardiális aritmiák kezelésében alkalmazható új biszpidinvegyületek, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk - Google Patents
Kardiális aritmiák kezelésében alkalmazható új biszpidinvegyületek, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásukInfo
- Publication number
- HUP0300244A2 HUP0300244A2 HU0300244A HUP0300244A HUP0300244A2 HU P0300244 A2 HUP0300244 A2 HU P0300244A2 HU 0300244 A HU0300244 A HU 0300244A HU P0300244 A HUP0300244 A HU P0300244A HU P0300244 A2 HUP0300244 A2 HU P0300244A2
- Authority
- HU
- Hungary
- Prior art keywords
- alkyl
- treatment
- preparation
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 206010003119 arrhythmia Diseases 0.000 title abstract 2
- PTPQJKANBKHDPM-UHFFFAOYSA-N 3,7-diazabicyclo[3.3.1]nonane Chemical class C1NCC2CNCC1C2 PTPQJKANBKHDPM-UHFFFAOYSA-N 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000005647 linker group Chemical group 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 230000006793 arrhythmia Effects 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 125000004446 heteroarylalkyl group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
- 125000005156 substituted alkylene group Chemical group 0.000 abstract 1
- 229910052717 sulfur Chemical group 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
A találmány tárgyát az általános képletű vegyületek - ahol R1 adottesetben alkil-, aril-alkil-, heteroaril-alkil-csoport; R2 és R3egymástól függetlenül hidrogénatom, adott esetben szubsztituáltalkilcsoport; R4 hidrogénatom vagy alkilcsoport; R5a, R5b, R5c, R5d,R5e és R5f egymástól függetlenül hidrogénatom vagy alkilcsoport; R6hidroxi-, ciano-, halogén-, amino-, nitro-, alkilcsoport; X oxigén-vagy kénatom; A és B egymástól függetlenül egyes kötés, adott esetbenszubsztituált alkiléncsoport vagy egyéb összekötő csoport; Dhidrogénatom, alkilcsoport vagy egyéb összekötő csoport - ésgyógyszerészetileg elfogadható származékaik és ezeket tartalmazó,aritmiák kezelésében alkalmazható gyógyszerkészítmények képezik. Atalálmány kiterjed a vegyületek előállítási eljárására is. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9902269A SE9902269D0 (sv) | 1999-06-16 | 1999-06-16 | Pharmaceutically active compounds |
| PCT/SE2000/001252 WO2000076998A1 (en) | 1999-06-16 | 2000-06-15 | New bispidine compounds useful in the treatment of cardiac arrhythmias |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0300244A2 true HUP0300244A2 (hu) | 2003-06-28 |
| HUP0300244A3 HUP0300244A3 (en) | 2003-12-29 |
Family
ID=20416101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0300244A HUP0300244A3 (en) | 1999-06-16 | 2000-06-15 | New bispidine compounds useful in the treatment of cardiac arrhythmias, process for their preparation, pharmaceutical compositions containing them and their use |
Country Status (28)
| Country | Link |
|---|---|
| EP (1) | EP1192156B1 (hu) |
| JP (1) | JP2003502327A (hu) |
| KR (1) | KR20020042534A (hu) |
| CN (1) | CN1187351C (hu) |
| AR (1) | AR024392A1 (hu) |
| AT (1) | ATE259809T1 (hu) |
| AU (1) | AU762040B2 (hu) |
| BR (1) | BR0011667A (hu) |
| CA (1) | CA2377395A1 (hu) |
| CZ (1) | CZ20014493A3 (hu) |
| DE (1) | DE60008377T2 (hu) |
| DK (1) | DK1192156T3 (hu) |
| EE (1) | EE200100679A (hu) |
| ES (1) | ES2214291T3 (hu) |
| HK (1) | HK1045689A1 (hu) |
| HU (1) | HUP0300244A3 (hu) |
| IL (1) | IL146751A0 (hu) |
| IS (1) | IS6200A (hu) |
| MX (1) | MXPA01012926A (hu) |
| NO (1) | NO20016120L (hu) |
| NZ (1) | NZ516014A (hu) |
| PL (1) | PL353155A1 (hu) |
| PT (1) | PT1192156E (hu) |
| SE (1) | SE9902269D0 (hu) |
| SK (1) | SK18292001A3 (hu) |
| TR (1) | TR200103635T2 (hu) |
| WO (1) | WO2000076998A1 (hu) |
| ZA (1) | ZA200109798B (hu) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR030302A1 (es) * | 2000-07-07 | 2003-08-20 | Astrazeneca Ab | Compuestos de bispidina, formulacion farmaceutica, uso para la fabricacion de medicamentos, proceso para la preparacion de estos compuestos y compuestos intermediarios |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT88381B (pt) * | 1987-09-09 | 1995-07-06 | Kali Chemie Pharma Gmbh | Processo para a preparacao de novos compostos 3,7-diazabiciclo{3,3,1} nonano, e de composicoes farmaceuticas que contem estes compostos |
| DE3732094A1 (de) * | 1987-09-24 | 1989-04-06 | Basf Ag | Bispidinderivate als klasse iii-antiarrhythmika |
| US5110933A (en) * | 1989-11-13 | 1992-05-05 | Board Of Regents Of Oklahoma State University | Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof |
| US5468858A (en) * | 1993-10-28 | 1995-11-21 | The Board Of Regents Of Oklahoma State University Physical Sciences | N-alkyl and n-acyl derivatives of 3,7-diazabicyclo-[3.3.1]nonanes and selected salts thereof as multi-class antiarrhythmic agents |
| SE9704709D0 (sv) * | 1997-12-17 | 1997-12-17 | Astra Ab | Pharmaceutically active compounds |
-
1999
- 1999-06-16 SE SE9902269A patent/SE9902269D0/xx unknown
-
2000
- 2000-06-15 EE EEP200100679A patent/EE200100679A/xx unknown
- 2000-06-15 AU AU60323/00A patent/AU762040B2/en not_active Ceased
- 2000-06-15 AT AT00946588T patent/ATE259809T1/de not_active IP Right Cessation
- 2000-06-15 DE DE60008377T patent/DE60008377T2/de not_active Expired - Fee Related
- 2000-06-15 PT PT00946588T patent/PT1192156E/pt unknown
- 2000-06-15 BR BR0011667-0A patent/BR0011667A/pt not_active IP Right Cessation
- 2000-06-15 MX MXPA01012926A patent/MXPA01012926A/es active IP Right Grant
- 2000-06-15 EP EP00946588A patent/EP1192156B1/en not_active Expired - Lifetime
- 2000-06-15 ES ES00946588T patent/ES2214291T3/es not_active Expired - Lifetime
- 2000-06-15 CZ CZ20014493A patent/CZ20014493A3/cs unknown
- 2000-06-15 HU HU0300244A patent/HUP0300244A3/hu unknown
- 2000-06-15 CN CNB008116075A patent/CN1187351C/zh not_active Expired - Fee Related
- 2000-06-15 WO PCT/SE2000/001252 patent/WO2000076998A1/en not_active Application Discontinuation
- 2000-06-15 DK DK00946588T patent/DK1192156T3/da active
- 2000-06-15 SK SK1829-2001A patent/SK18292001A3/sk unknown
- 2000-06-15 CA CA002377395A patent/CA2377395A1/en not_active Abandoned
- 2000-06-15 KR KR1020017016167A patent/KR20020042534A/ko not_active Application Discontinuation
- 2000-06-15 NZ NZ516014A patent/NZ516014A/xx unknown
- 2000-06-15 PL PL00353155A patent/PL353155A1/xx not_active Application Discontinuation
- 2000-06-15 IL IL14675100A patent/IL146751A0/xx unknown
- 2000-06-15 TR TR2001/03635T patent/TR200103635T2/xx unknown
- 2000-06-15 JP JP2001503856A patent/JP2003502327A/ja active Pending
- 2000-06-16 AR ARP000103016A patent/AR024392A1/es unknown
- 2000-12-14 IS IS6200A patent/IS6200A/is unknown
-
2001
- 2001-11-28 ZA ZA200109798A patent/ZA200109798B/en unknown
- 2001-12-14 NO NO20016120A patent/NO20016120L/no not_active Application Discontinuation
-
2002
- 2002-09-26 HK HK02107114.4A patent/HK1045689A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2214291T3 (es) | 2004-09-16 |
| MXPA01012926A (es) | 2002-07-30 |
| DK1192156T3 (da) | 2004-05-17 |
| AR024392A1 (es) | 2002-10-02 |
| KR20020042534A (ko) | 2002-06-05 |
| JP2003502327A (ja) | 2003-01-21 |
| AU6032300A (en) | 2001-01-02 |
| CZ20014493A3 (cs) | 2002-05-15 |
| SK18292001A3 (sk) | 2002-12-03 |
| PT1192156E (pt) | 2004-06-30 |
| AU762040B2 (en) | 2003-06-19 |
| ZA200109798B (en) | 2003-02-28 |
| NZ516014A (en) | 2003-06-30 |
| BR0011667A (pt) | 2002-04-02 |
| HK1045689A1 (zh) | 2002-12-06 |
| WO2000076998A1 (en) | 2000-12-21 |
| EP1192156B1 (en) | 2004-02-18 |
| IS6200A (is) | 2001-12-14 |
| IL146751A0 (en) | 2002-07-25 |
| CN1187351C (zh) | 2005-02-02 |
| WO2000076998B1 (en) | 2001-03-08 |
| SE9902269D0 (sv) | 1999-06-16 |
| CN1370165A (zh) | 2002-09-18 |
| DE60008377D1 (de) | 2004-03-25 |
| TR200103635T2 (tr) | 2002-04-22 |
| EE200100679A (et) | 2003-02-17 |
| PL353155A1 (en) | 2003-10-20 |
| HUP0300244A3 (en) | 2003-12-29 |
| NO20016120L (no) | 2002-02-18 |
| CA2377395A1 (en) | 2000-12-21 |
| ATE259809T1 (de) | 2004-03-15 |
| EP1192156A1 (en) | 2002-04-03 |
| DE60008377T2 (de) | 2004-12-09 |
| NO20016120D0 (no) | 2001-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0401740A2 (hu) | N-szubsztituált hidroxipirimidinon-karboxamid HIV-integráz inhibitorok és ezeket tartalmazó gyógyszerkészítmények | |
| ME00513B (me) | Azabicikloalkani kao modulatori ccr5 | |
| HUP0203458A2 (hu) | Nociceptin ORL-1 receptor agonisták alkalmazása köhögés kezelésére és ezeket tartalmazó gyógyszerkészítmények | |
| DK0958296T3 (da) | Heterocykliske forbindelser, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem, og deres anvendelse i behandlingen af diabetes og beslægtede sygdomme | |
| HUP0301722A2 (hu) | Pirimidinszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| EA199800943A1 (ru) | Производные мочевины и их применение в качестве ингибиторов инозин-5`-монофосфат- дегидрогеназы | |
| TR200002480T2 (tr) | İzaşemi tedavisi için guanidin türevleri | |
| HUP0100388A2 (hu) | Készítmények és eljárások csontritkulás kezelésére és a koleszterinszint csökkentésére | |
| HUP0105231A2 (hu) | Heteroaril-szubsztituált kinolin-2-on-származék rákellenes szerek és a vegyületeket tartalmazó gyógyszerkészítmények | |
| EE04911B1 (et) | Ühend ja farmatseutiline kompositsioon proteaasi inhibiitoritena, nende kasutamine ning meetod selle ühendi valmistamiseks | |
| HUP0202795A2 (hu) | Pirimidin- és pirazinszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| DE69940769D1 (de) | Orale flüssige zusammensetzungen | |
| EA200100992A1 (ru) | Ингибиторы фермента impdh | |
| PT966465E (pt) | Inibidores do enzima imfdh | |
| HUP0100156A2 (hu) | Foszfolipáz-A2 inhibitor hatású indolszármazékok és alkalmazásuk gyógyászati készítmények előállítására | |
| IL149163A0 (en) | Piperazine derivatives of carbazole, their preparation and pharmaceutical compositions containing them | |
| NO20066055L (no) | Pyridinderivater | |
| HUP0101999A2 (hu) | 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása | |
| NO302474B1 (no) | Sakarinderivater, farmasöytisk sammensetning og anvendelse derav | |
| YU47116B (sh) | Postupak za dobijanje novih n-supstituisanih benzimidazolskih derivata | |
| NO20050666L (no) | 2,7-substituerte indoler og deres anvendelse som 5-HT6 modulatorer | |
| EP0119161A3 (en) | Benzazoquinone and benzazoninone derivatives, process for their preparation, their pharmaceutical preparations as well as their therapeutic use | |
| NO20060146L (no) | Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav | |
| HUP0301032A2 (hu) | Ciklin-dependens kinázok N-{5-[(5-alkil-2-oxazolil)-metil-tio]-2-tiazolil}-karboxamid inhibitorai, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0103203A2 (hu) | Azaadamantánszármazékok és ezeket tartalmazó gyógyszerkészítmények |